Faeth Therapeutics, Inc. (FTH) vs Verastem, Inc. (VSTM)
A side-by-side comparison of Faeth Therapeutics, Inc. and Verastem, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FTH
Faeth Therapeutics, Inc.
$26.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VSTM
Verastem, Inc.
$7.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FTH vs VSTM
growth of $100 · dividends reinvested · last 6yFTH -92.8% (-35.5%/yr)VSTM -67.3% (-17.0%/yr)VSTM compounded faster over this window
FTH VSTM
FTH vs VSTM: by the numbers
- •FTH is the larger company ($693M vs $681M market cap).
- •Both run net losses; FTH's is the smaller (0.00% vs -231.59% net margin).
Metrics side by side
Valuation
| Metric | FTH | VSTM |
|---|---|---|
| P/S ratio | N/A | 7.78 |
| P/B ratio | 4.01 | 13.62 |
Profitability
| Metric | FTH | VSTM |
|---|---|---|
| Gross margin | 0.00% | 86.69% |
| Operating margin | 0.00% | -550.33% |
| Net margin | 0.00% | -231.59% |
| ROE | -113.05% | -405.51% |
| ROIC | -110.62% | -118.97% |
Growth (annualized)
| Metric | FTH | VSTM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -18.98% |
| Total return CAGR (5Y) | -31.75% | -25.22% |
Frequently asked
- How have FTH and VSTM total returns compared?
- Over the past 5 years, FTH delivered -31.75% and VSTM delivered -25.22% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.